Thursday, October 7, 2021

12th European Congress on Tropical Medicine and International Health (ECTMIH)

  Abstract

(Poster Presentation on Virtual 12th ECTMIH; Sept 28 - Oct 1, 2021)

Tropical Medicine & International Health volume 26 suppl 1 pp 41 September 2021

 

324

Emergence of multi-drug resistant bacterial infection of lower respiratory tract among people living with HIV

R. Maharjan1, A. Bastola2, N. Adhikari1, K. R. Rijal1, P. Ghimire1 and U. T. Shrestha1

1Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal;

2Sukraraj Tropical and Infectious Disease Hospital, Teku, Kathmandu, Nepal

 

BIOGRAPHY: Upendra Thapa Shrestha, Lecturer, Central Department of Microbiology, Tribhuvan University, Kathmandu Nepal (Institutional Email: upendra.thapashrestha@ cdmi.tu.edu.np). Currently; PhD Scholar; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand (Email: upendrathapa.shr@student.mahidol.edu).

Goal: Applied Molecular Microbiology research and its application in human beings

Publications: More than 24 articles in national and international journals

Current status: working on diagnosis of acute undifferentiated febrile illness with focus on arboviral infections using multiplex real-time RT-PCR based on three tertiary care hospitals in Nepal Research Grants Awarded from: University Grants Commission, Nepal, Ministry of Science and Technology, Nepal, USAID, USA

Other interested research area: Malaria, antimicrobial resistance

 

OBJECTIVES This study aimed to determine the prevalence of lower respiratory tract infection among HIV due to multidrug-resistant pathogens and to detect plasmid-mediated blaTEM and bla CTX-M genes among Extended-Spectrum Beta-Lactamase (ESBL) producing isolates from sputum samples in Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal.

METHODS A total of 263 sputum samples from confirmed HIV-positive cases were processed with standard microbiological methods to isolate and identify the possible pathogens. The identified bacterial isolates were subjected to antibiotic susceptibility testing using modified Kirby Bauer disk diffusion following Clinical Laboratory Standard Institute (CLSI) guidelines. Multidrug-resistant and ESBL producers were screened and confirmed. Plasmids from those ESBL producers and Mstrains were extracted and screened for ESBL genes; blaCTX and blaTEM by conventional PCR method using specific primers.

RESULTS of 263 sputum samples, 67 (25.5%) were culture positive showing Klebsiella pneumoniae (17, 25.4%) as the most predominant one. A higher rate of infection (4/8, 50%) was seen among older people of 6170 years, whereas no infection was seen below age 20. About 30.0% (n = 15) of smokers, 32.9% (n = 23) cases with previous pulmonary tuberculosis and 39.8% (n = 7) of people with CD4 counts <200 cells/μl were found to be more susceptible towards LRTIs. Among 53 bacterial isolates in Enterobacteriaceae family, 52.8% (n = 28) were multidrug-resistant and 43.3% (n = 23) were ESBL producers. All ESBL producers were sensitive to Colistin and Polymyxin B. of 23 ESBL producers, 95.6% (n = 22) and 52.1% (n = 12) possessed blaCTX-M and blaTEM genes respectively in their plasmid, which may transfer both vertically and horizontally resulting in higher rate of ESBL producers.

CONCLUSION The increasing rate of bacterial infections mainly ESBL producers of LRTIs among people with HIV causes difficulty in the management of diseases leading to high morbidity and mortality among HIV patients.

KEYWORDS: HIV, Lower respiratory tract infection, ELBL, blaCTX, blaTEM



Wednesday, September 8, 2021

Chemotherapy/Antimicrobial Section/Original Paper

 Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal

 

Sabita Thapaa Nabaraj Adhikarib Anil Kumar Shahc Ishworiya Lamichhanea Binod Dhungelb Upendra Thapa Shresthab Bipin Adhikarid Megha Raj Banjarab Prakash Ghimireb Komal Raj Rijalb

 

aKantipur College of Medical Sciences, Kathmandu, Nepal;

bCentral Department of Microbiology, Tribhuvan University, Kathmandu, Nepal;

cAnnapurna Neurological Institute and Allied Sciences, Kathmandu, Nepal; 

dNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK

ABSTRACT

Background: Klebsiella pneumoniae is one of the leading causes of nosocomial infections. Carbapenems are used as the last resort for the treatment of multidrug resistant Gram-negative bacterial infections. In recent years, resistance to these lifesaving drugs has been increasingly reported due to the production of carbapenemase. The main objective of this study was to detect the carbapenem-resistant genes blaNDM-1 and blaVIM in K. pneumoniae isolated from different clinical specimens. Methods: A total of 585 clinical specimens (urine, pus, sputum, blood, catheter tips, and others) from human subjects attended at Annapurna Neurological Institute and Allied Sciences, Kathmandu were obtained in the period between July 2018 and January 2019. The specimens were isolated and identified for K. pneumoniae. All Kpneumoniae isolates were processed for antimicrobial susceptibility testing (AST) using the disk diffusion method. The isolates were further phenotypically confirmed for carbapenemase production by the modified Hodge test (MHT) using imipenem (10 μg) and meropenem (10 μg) discs. Thus, confirmed carbapenemase-producing isolates were further screened for the production of blaNDM-1 and blaVIM using conventional polymerase chain reaction (PCR). Results: Among the clinical isolates tested, culture positivity was 38.29% (224/585), and the prevalence of K. pneumoniae was 25.89% (58/224). On AST, K. pneumoniae exhibited resistance toward carbapenems including ertapenem, meropenem, and imipenem, while it showed the highest susceptibility rate against to tigecycline (93.1%; 54/58). Overall, AST detected 60.34% (35/58) carbapenem-resistant isolates, while the MHT phenotypically confirmed 51.72% (30/58) isolates as carbapenemase-producers and 48.28% (28/58) as carbapenemase nonproducers. On subsequent screening for resistant genes among carbapenemase-producers by PCR assay, 80% (24/30) and 3.33% (1/30) isolates were found to be positive for blaNDM-1 and blaVIM, respectively. In the same assay among 28 carbapenem nonproducing isolates, 9 (32.14%) isolates were positive for blaNDM-1 gene while none of them were tested positive for blaVIM gene. Conclusions: Molecular detection of resistant genes provides greater specificity and sensitivity than those with conventional techniques, thus aiding in accurate identification of antimicrobial resistance and clinical management of the disease

 

Keywords: Klebsiella pneumoniae, New Delhi metallo-betalactamase-1, Verona integron-encoded metallo-betalactamase, Carbapenem, Modified Hodge test, Multidrug resistance, Antibiotic susceptibility test


Citation: Thapa S, Adhikari N, Shah A, K, Lamichhane I, Dhungel B, Shrestha U, T, Adhikari B, Banjara M, R, Ghimire P, Rijal K, R: Detection of NDM-1 and VIM Genes in Carbapenem-Resistant <b><i>Klebsiella pneumoniae</i></b> Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal. Chemotherapy 2021. doi: 10.1159/000518256

Fulltext: Download

Tuesday, August 24, 2021

Know about the Delta Variant from WHO’s Dr Maria Van Kerkhove

 DELTA VARIANT



Bacteria in Photos

Bacteria in Photos